Hemostats for wound closure sales will expand through 2036, with orthopedic surgery holding 38% of the application segment in 2026, driven by increasing clinical adoption and expanding procedural volume across hospital systems. The market was valued at USD 2.88 billion in 2025 and is expected to be worth USD 5.52 billion by 2036.